Romy Zemel

1.6k total citations
46 papers, 1.3k citations indexed

About

Romy Zemel is a scholar working on Hepatology, Epidemiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Romy Zemel has authored 46 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Hepatology, 20 papers in Epidemiology and 13 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Romy Zemel's work include Hepatitis C virus research (21 papers), Hepatitis B Virus Studies (15 papers) and Monoclonal and Polyclonal Antibodies Research (13 papers). Romy Zemel is often cited by papers focused on Hepatitis C virus research (21 papers), Hepatitis B Virus Studies (15 papers) and Monoclonal and Polyclonal Antibodies Research (13 papers). Romy Zemel collaborates with scholars based in Israel, United States and France. Romy Zemel's co-authors include Ran Tur‐Kaspa, L. Bachmetov, Meital Gal-Tanamy, Itai Benhar, Avi Golan‐Goldhirsh, Ruth Koren, Zelig Eshhar, Amiram Ravid, A. Erman and Ziv Ben‐Ari and has published in prestigious journals such as The Lancet, Gastroenterology and PLoS ONE.

In The Last Decade

Romy Zemel

45 papers receiving 1.2k citations

Peers

Romy Zemel

HEPAT

EPIDE

RNMI

In Hee Kim South Korea

Meital Gal-Tanamy Israel

Céline Hernandez France

Masahiko Kaito Japan

Sameera Ezzat Egypt

Jonathan Booth United Kingdom

Masaaki Korenaga Japan

Adolfo Suárez Spain

Shengdi Wu China

Xiaoli Jia China

In Hee Kim South Korea

Romy Zemel

459 ×0.9

HEPAT

615 ×1.2

EPIDE

595 ×1.5

88 ×0.4

RNMI

118 ×0.9

Citations per year, relative to Romy Zemel Romy Zemel (= 1×) peers In Hee Kim

Countries citing papers authored by Romy Zemel

Since Specialization

Citations

This map shows the geographic impact of Romy Zemel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Romy Zemel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Romy Zemel more than expected).

Fields of papers citing papers by Romy Zemel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Romy Zemel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Romy Zemel. The network helps show where Romy Zemel may publish in the future.

Co-authorship network of co-authors of Romy Zemel

This figure shows the co-authorship network connecting the top 25 collaborators of Romy Zemel. A scholar is included among the top collaborators of Romy Zemel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Romy Zemel. Romy Zemel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kornowski, Ran, Maayan Waldman, Romy Zemel, et al.. (2021). Leptin modulates gene expression in the heart, cardiomyocytes and the adipose tissue thus mitigating LPS-induced damage. Experimental Cell Research. 404(2). 112647–112647. 14 indexed citations

Hochhauser, Edith, Orna Avlas, Romy Zemel, et al.. (2013). Bone Marrow and Nonbone Marrow Toll Like Receptor 4 Regulate Acute Hepatic Injury Induced by Endotoxemia. PLoS ONE. 8(8). e73041–e73041. 11 indexed citations

Zemel, Romy, et al.. (2012). The use of epitope arrays in immunodiagnosis of infectious disease: Hepatitis C virus, a case study. Analytical Biochemistry. 432(2). 63–70. 9 indexed citations

Ari, Ziv Ben, Orna Avlas, Orit Pappo, et al.. (2012). Reduced Hepatic Injury in Toll-Like Receptor 4–Deficient Mice Following D-Galactosamine/Lipopolysaccharide-Induced Fulminant Hepatic Failure. Cellular Physiology and Biochemistry. 29(1-2). 41–50. 78 indexed citations

Gal-Tanamy, Meital, L. Bachmetov, Amiram Ravid, et al.. (2011). Vitamin D: An innate antiviral agent suppressing hepatitis C virus in human hepatocytes. Hepatology. 54(5). 1570–1579. 151 indexed citations

Gal-Tanamy, Meital, Romy Zemel, Rohit K. Jangra, et al.. (2010). Inhibition of protease-inhibitor-resistant hepatitis C virus replicons and infectious virus by intracellular intrabodies. Antiviral Research. 88(1). 95–106. 14 indexed citations

Vorobeychik, M., Konstantin Bloch, Romy Zemel, et al.. (2008). Immunohistochemical evaluation of hepatic oval cell activation and differentiation toward pancreatic beta-cell phenotype in streptozotocin-induced diabetic mice. Journal of Molecular Histology. 39(4). 463–468. 9 indexed citations

Gal-Tanamy, Meital, et al.. (2008). Inhibition of hepatitis C virus RNA replicons by peptide aptamers. Antiviral Research. 77(3). 195–205. 15 indexed citations

Shemer‐Avni, Yonat, Michal Cohen, Ayelet Keren‐Naus, et al.. (2007). Iatrogenic Transmission of Hepatitis C Virus (HCV) by an Anesthesiologist: Comparative Molecular Analysis of the HCV-E1 and HCV-E2 Hypervariable Regions. Clinical Infectious Diseases. 45(4). e32–e38. 19 indexed citations

10.

Gal-Tanamy, Meital, et al.. (2005). HCV NS3 Serine Protease-neutralizing Single-chain Antibodies Isolated by a Novel Genetic Screen. Journal of Molecular Biology. 347(5). 991–1003. 19 indexed citations

11.

Ben‐Ari, Ziv, Romy Zemel, & Ran Tur‐Kaspa. (2001). THE ADDITION OF MYCOPHENOLATE MOFETIL FOR SUPPRESSING HEPATITIS B VIRUS REPLICATION IN LIVER RECIPIENTS WHO DEVELOPED LAMIVUDINE RESISTANCE. Transplantation. 71(1). 154–156. 13 indexed citations

12.

Zemel, Romy, et al.. (2000). Mutations at Vicinity of Catalytic Sites of Hepatitis C Virus NS3 Serine Protease Gene Isolated from Hepatocellular Carcinoma Tissue. Digestive Diseases and Sciences. 45(11). 2199–2202. 5 indexed citations

13.

Ben‐Ari, Ziv, Didier Samuel, Romy Zemel, et al.. (2000). Fulminant Non–A-G Viral Hepatitis Leading to Liver Transplantation. Archives of Internal Medicine. 160(3). 388–388. 14 indexed citations

14.

Bloch, Konstantin, et al.. (1999). Streptozotocin and Alloxan‐based Selection Improves Toxin Resistance of Insulin‐Producing RINm Cells. Journal of Diabetes Research. 1(3). 211–219. 20 indexed citations

15.

Ben‐Ari, Ziv, et al.. (1999). Efficacy of Lamivudine in Patients With Hepatitis B Virus Precore Mutant Infection Before and After Liver Transplantation. The American Journal of Gastroenterology. 94(3). 663–667. 18 indexed citations

16.

Ben‐Ari, Ziv, et al.. (1999). ASSOCIATION OF LAMIVUDINE RESISTANCE IN RECURRENT HEPATITIS B AFTER LIVER TRANSPLANTATION WITH ADVANCED HEPATIC FIBROSIS. Transplantation. 68(2). 232–236. 23 indexed citations

17.

Lustig, S., Romy Zemel, Ram Dickman, et al.. (1997). Hepatitis HGV/GBV-C viremia in renal transplant recipients. Transplantation Proceedings. 29(6). 2694–2695. 1 indexed citations

18.

Gigant, Benoı̂t, Jean‐Baptiste Charbonnier, Béatrice Golinelli‐Pimpaneau, et al.. (1997). Mechanism of Inactivation of a Catalytic Antibody by P‐Nitrophenyl Esters. European Journal of Biochemistry. 246(2). 471–476. 9 indexed citations

19.

Golinelli‐Pimpaneau, Béatrice, Benoı̂t Gigant, Thierry Bizebard, et al.. (1994). Crystal structure of a catalytic antibody Fab with esterase- like activity. Structure. 2(3). 175–183. 52 indexed citations

20.

Zemel, Romy, et al.. (1990). Simple method for selecting catalytic monoclonal antibodies that exhibit turnover and specificity. Biochemistry. 29(42). 9916–9921. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact